AAAAAA
Results: 151-175/482
Authors:
Roussel, P
Citation: P. Roussel, Quality continuous improvement and implementation of a non conformity detection system, TRANSF CL B, 6(2), 1999, pp. 136-141
Authors:
Chevrolle, F
Citation: F. Chevrolle, The medico-technical inspection of blood transfusion centers, TRANSF CL B, 6(2), 1999, pp. 142-147
Authors:
Lapierre, V
Kuentz, M
Tiberghien, P
Citation: V. Lapierre et al., Erythrocyte transfusions after allogeneic hematopoietic stem cell graft, TRANSF CL B, 6(2), 1999, pp. 148-152
Authors:
Rouger, P
Cartron, JP
Citation: P. Rouger et Jp. Cartron, Prion diseases and blood transfusion, TRANSF CL B, 6(1), 1999, pp. 5-6
Authors:
Rieger, R
Lasmezas, CI
Weiss, S
Citation: R. Rieger et al., Role of the 37 kDa laminin receptor precursor in the life cycle of prions, TRANSF CL B, 6(1), 1999, pp. 7-16
Authors:
Brandner, S
Klein, MA
Aguzzi, A
Citation: S. Brandner et al., A crucial role for B cells in neuroinvasive scrapie, TRANSF CL B, 6(1), 1999, pp. 17-23
Authors:
Beauvais, P
de Villemeur, TB
Citation: P. Beauvais et Tb. De Villemeur, Prion diseases and blood transfusion, TRANSF CL B, 6(1), 1999, pp. 24-28
Authors:
Bruce, ME
Citation: Me. Bruce, Pathogenesis and pathology in animal TSE models, TRANSF CL B, 6(1), 1999, pp. 29-30
Authors:
Will, RG
Citation: Rg. Will, The new variant of CJD, TRANSF CL B, 6(1), 1999, pp. 30-30
Authors:
Wuthrich, K
Riek, R
Wider, G
Garcia, FL
Liu, A
Zahn, R
Billeter, M
Hornemann, S
Glockshuber, R
Citation: K. Wuthrich et al., Structural biology of prion proteins, TRANSF CL B, 6(1), 1999, pp. 31-31
Authors:
Brendel, JP
Citation: Jp. Brendel, Iatrogenic accidents, TRANSF CL B, 6(1), 1999, pp. 32-33
Authors:
Mouchet, J
Citation: J. Mouchet, Vectors and environmental factors in malaria, TRANSF CL B, 6(1), 1999, pp. 35-43
Authors:
Mercereau-Puijalon, O
Citation: O. Mercereau-puijalon, Molecular characteristics of Plasmodium falciparum infections in man, TRANSF CL B, 6(1), 1999, pp. 44-56
Authors:
Newbold, C
Craig, A
Kyes, S
Rowe, A
Fernandez-Reyes, D
Fagan, T
Citation: C. Newbold et al., Plasmodium falciparum: Pathogenesis, polymorphism and the infected red cell surface, TRANSF CL B, 6(1), 1999, pp. 57-60
Authors:
Chitnis, C
Ranjan, A
Singh, S
Pandey, K
Citation: C. Chitnis et al., Molecular interactions involved in red cell invasion by malarial parasites, TRANSF CL B, 6(1), 1999, pp. 60-61
Authors:
Braun-Breton, C
Citation: C. Braun-breton, Enzyme activities involved in Plasmodium falciparum invasion of erythrocytes, TRANSF CL B, 6(1), 1999, pp. 61-62
Authors:
Mazier, D
Boubou, MI
Cazenave, PA
Pied, S
Citation: D. Mazier et al., T-cell response: Immunopathology and immunoprotection, TRANSF CL B, 6(1), 1999, pp. 63-63
Authors:
Nussenzweig, V
Citation: V. Nussenzweig, Rationale for the development of a malaria vaccine, TRANSF CL B, 6(1), 1999, pp. 64-64
Authors:
Le Bras, J
Citation: J. Le Bras, Malaria and chemoresistance, TRANSF CL B, 6(1), 1999, pp. 64-64
Authors:
Laperche, S
Citation: S. Laperche, Creutzfeldt-Jakob disease and blood transfusion-related risk in 1998, TRANSF CL B, 6(1), 1999, pp. 67-71
Authors:
Rouger, P
Citation: P. Rouger, From malaria to transfusion-induced malaria., TRANSF CL B, 6(1), 1999, pp. 72-74
Authors:
Colin, Y
Citation: Y. Colin, Short lexicon of molecular genetics, TRANSF CL B, 6(1), 1999, pp. 75-79
Authors:
PILLONEL J
SAURA C
COUROUCE AM
Citation: J. Pillonel et al., PREVALENCE OF HIV, HTLV, HBV AND HVC IN BLOOD-DONORS IN FRANCE, 1992-1996, Transfusion clinique et biologique, 5(5), 1998, pp. 305-312
Authors:
DANIC B
BEAUPLET A
Citation: B. Danic et A. Beauplet, BENEFITS AND RISKS OF SCHEDULED AUTOLOGOUS BLOOD-TRANSFUSION, Transfusion clinique et biologique, 5(5), 1998, pp. 313-325
Authors:
FERRERA V
STACCINI P
CHIARONI J
QUARANTA JF
BOULAY F
DEMICCO P
Citation: V. Ferrera et al., DATA INTERCHANGE IN THE AREA OF BLOOD-TRANSFUSION - IMPACT OF A NEW STANDARD UPON THE EVOLUTION OF EDI IN FRENCH HEALTH-CARE, Transfusion clinique et biologique, 5(5), 1998, pp. 326-335